Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ziporen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Lupus|November 14, 1998
Lessons from experimental APS modelsY Shoenfeld, L Ziporen
Hematology and Cell Therapy|December 9, 1998
Anti-phospholipid syndrome: from patient's bedside to experimental animal models and back to the patient's bedsideL Ziporen, Y Shoenfeld
Rheumatic Diseases Clinics of North America|February 1, 1997
Animal models for antiphospholipid syndrome in pregnancyL Ziporen, M Blank, Y Shoenfeld
Harefuah|May 15, 1997
[Libman-Sacks endocarditis--a jubilee year]A Afek, L Ziporen, Y Shoenfeld
Circulation|April 15, 1996
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndromeM Hojnik, J George, L Ziporen, et al.
The Journal of Clinical Investigation|August 1, 1997
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse modelL Ziporen, Y Shoenfeld, Y Levy, et al.
Clinical Rheumatology|September 12, 2002
Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratoryR Mader, L Ziporen, R Mader, et al.
Clinical and Experimental Immunology|February 4, 2003
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acidN Donin, K Jurianz, L Ziporen, et al.
Annales De Medecine Interne|September 1, 1996
Do some antiphospholipid antibodies target endothelial cells?M Dueymes, Y Levy, L Ziporen, et al.
Clinical and Experimental Rheumatology|July 1, 1996
Superantigens and experimental SLE induced by idiotypic dysregulationE Baharav, H Gur, P Fishman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Lupus|November 14, 1998
Lessons from experimental APS modelsY Shoenfeld, L Ziporen
Hematology and Cell Therapy|December 9, 1998
Anti-phospholipid syndrome: from patient's bedside to experimental animal models and back to the patient's bedsideL Ziporen, Y Shoenfeld
Rheumatic Diseases Clinics of North America|February 1, 1997
Animal models for antiphospholipid syndrome in pregnancyL Ziporen, M Blank, Y Shoenfeld
Harefuah|May 15, 1997
[Libman-Sacks endocarditis--a jubilee year]A Afek, L Ziporen, Y Shoenfeld
Circulation|April 15, 1996
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndromeM Hojnik, J George, L Ziporen, et al.
The Journal of Clinical Investigation|August 1, 1997
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse modelL Ziporen, Y Shoenfeld, Y Levy, et al.
Clinical Rheumatology|September 12, 2002
Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratoryR Mader, L Ziporen, R Mader, et al.
Clinical and Experimental Immunology|February 4, 2003
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acidN Donin, K Jurianz, L Ziporen, et al.
Annales De Medecine Interne|September 1, 1996
Do some antiphospholipid antibodies target endothelial cells?M Dueymes, Y Levy, L Ziporen, et al.
Clinical and Experimental Rheumatology|July 1, 1996
Superantigens and experimental SLE induced by idiotypic dysregulationE Baharav, H Gur, P Fishman, et al.
Pageof 2